Breaking News

WuXi PharmaTech Completes St. Paul Facility Expansion

May 12, 2014

Expands materials characterization testing services in St. Paul

WuXi PharmaTech, Inc. has completed the expansion of its materials characterization testing facility in St. Paul, MN. The new lab will begin operations by the end of June. 
 
The new 20,000-sq.-ft. lab will offer expanded capacity for existing services, such as particle identification and extractable/leachable testing, and its new service, dynamic light scattering for nanoparticle characterization. The expansion is designed to allow rapid scale-up of technologies to increase capacities for chemical analysis of medical materials.  
 
"WuXi is committed to helping medical device and biologics companies bring their products to market faster," said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. "This facility and WuXi's trained staff will better serve our customers' growing need to quantify the chemical safety of materials used in medical devices and biologics."
  • Analytical Testing Outsourcing Trends Update

    Analytical Testing Outsourcing Trends Update

    January 26, 2017
    Spurred by many factors, global analytical testing services market is experiencing rapid growth in the range of 11% per year

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research